阿魏酸钠对高原慢性肺源性心脏病急性加重期患者高凝状态的影响  

Effects of Sodium Ferulate treatment on the hypercoagulability of patients with plateau derived chronic cor pulmonale with acute ecacerbation phase at high altitude

作　　者：张瑛[1] 唐群科[1] 袁春萍[1] 王玉孝[1] 

机构地区：[1]解放军第四医院内一科,西宁810007

出　　处：《中国综合临床》2014年第4期387-389,共3页Clinical Medicine of China

摘　　要：目的 探讨注射用阿魏酸钠对高原慢性肺源性心脏病（肺心病）患者急性加重期高凝状态的影响.方法 41例慢性肺心病急性加重期患者,随机分为治疗组22例,对照组19例.两组患者均给予常规抗感染、祛痰止咳、纠正水电解质紊乱、持续低流量吸氧、超声雾化吸入治疗.治疗组静脉滴注阿魏酸钠300 mg,1次/d治疗,2周为1疗程.治疗前后检查血流变、肝肾功能.结果 治疗组治疗后与治疗前比较,全血高切黏度[（4.91±1.60）、（5.78±1.65） mPa·s,P=0.042]、血浆黏度[（1.56±0.49）、（1.87±0.65） mPa·s,P=0.041]明显下降.对照组上述指标治疗前后差异均无统计学意义（P均＞0.05）.两组治疗后肝肾功能无异常变化.结论 阿魏酸钠对高原慢性肺心病急性加重期患者血液高凝状态的治疗有效.Objective To explore the effects of Sodium Ferulateon treating patients with plateau derived chronic cor pulmonale in acute ecacerbation phase at high altitude.Methods Forty-one cases with plateau derived chronic cor pulmonale were randomly divided into treatment group （22 cases） and control group （19 cases）.All the patients in the two groups were given the same routine treatments including anti-infection,expectorant,balancing hydro-electrolytic discord,persistent inspiration of low-flow oxygen and inhalation by ultrasonic nebulization.Patients in treatment group were plus given the Sodium Ferulate at dose of 300 mg by intravenous drop once daily for 2 weeks.Hemorrheology,hepatic and renal function were examined.Results After treatment,the level of whole blood viscosity and plasma viscosity in treatment group were （4.91 ± 1.60） mPa · s and （1.56 ± 0.49） mPa · s,lower than that before treatment （（5.78 ± 1.65） mPa · s and （1.87 ± 0.65） mPa · s,P =0.042,0.041）.There were no significant difference in the control group in terms of whole blood viscosity and plasma viscosity.There was not abnormal change of hepatic and renal function of two groups after treatment.Conclusion Sodium Ferulate therapy was effective to treatment of the plateau derived chronic cor pulmonale in acute ecacerbation phase.

关 键 词：肺心病 高凝状态 阿魏酸钠 

分 类 号：R541.5[医药卫生—心血管疾病]